Mercaptor Discoveries

5 Hamilton Landing
Suite 160
Novato
California
94949
United States

Tel: 415-870-7056
Fax: 415-993-1227

About Mercaptor Discoveries

Mercaptor Discoveries is a privately held company that was founded in October 2016 by a team of scientists who had stumbled onto some interesting structure-activity relationships with clear potential. Rather than let the discovery languish for absence of a path-to-sales within a year, they took a leap of faith and became a self-seeded enterprise with a clear goal: Limiting pathologies associated with Alzheimer's disease, ALS, chronic traumatic encephalopathy, Parkinson's disease, stroke, epilepsy and other debilitating conditions in animals and man. Headquartered in Novato, California, Mercaptor prioritizes science, promotes productivity and transparency, and values the purity of research.
YEAR FOUNDED:
October 2016
LEADERSHIP:
CEO: Sara Isbell

11 articles about Mercaptor Discoveries

Mercaptor Discoveries Uses its Proprietary Neurotherapeutic Platform to Develop Treatment for COVID-19

5/18/2020

Mercaptor Discoveries (Mercaptor), a platform company with preclinical programs in epilepsy and TBI, today announced that it is pivoting its proprietary neurotherapeutic development plan toward COVID-19.
Mercaptor Discoveries Bets on Captons™ to Reinvigorate the Stalled Promise of Stem Cells

8/26/2019

Bringing stem cells into their strategy opens the door for treatments in brain tumors such as Glioblastoma
Mercaptor Discoveries CEO to Speak at 9th Annual Traumatic Brain Injury Conference in Washington D.C. May 16, 2019

3/4/2019

Sara Isbell, CEO, President and Co-Founder of Mercaptor Discoveries, will be a speaker at the 9th Annual Traumatic Brain Injury Conference in Washington D.C. on May 16, 2019.
Mercaptor Announces Publication of Patent Application Covering Foundational Technology

11/21/2018

Mercaptor Discoveries, a pharmaceutical company focused on developing unprecedented technology addressing significant unmet medical needs, today announced the publication of its patent application WO 2018/200527 A1, "Use of thiol compounds to treat neurological disease."
BioSpace Movers and Shakers Oct. 29

10/29/2018

Biopharma companies shore up leadership roles with new hires and appointments, at Axcella Health, Twist Bioscience, and more.
Bay Area Biotech Mercaptor Discoveries Appoints World-Renowned Neuropathologist, Dr. Adriano Aguzzi to Scientific Advisory Board

10/25/2018

Mercaptor Discoveries announced today that Dr. Adriano Aguzzi, MD, PhD, is heading up the formation of its Scientific Advisory Board (SAB).
Mercaptor Announces the Appointment of World-Renowned Neuropathologist, Dr. Adriano Aguzzi to Scientific Advisory Board

10/25/2018

Mercaptor Discoveries announced today that Dr. Adriano Aguzzi, MD, PhD, is heading up the formation of its Scientific Advisory Board (SAB). D
Mercaptor Discoveries Announces Positive Preclinical Proof of Concept (POC) in NIH-Funded Studies

10/12/2018

Mercaptor Discoveries (Mercaptor) today announced that its proprietary Capton® molecule demonstrated efficacy in the Epilepsy Therapy Screening Program (ETSP) run by the National Institutes of Health –National Institute Of Neurological Disorders And Stroke
Mercaptor Discoveries cracks the code: develops injury-activated drugs that treat brain trauma

4/18/2018

Mercaptor Discoveries was founded to explore the potential of their core research team's discovery, "captons," in neuroprotection and to harness the power of these small molecules to treat brain injuries in situ, where the need is most urgent.
Redefining Translational Science, Jarrod Tremayne, PhD , Is Appointed Vice President Of Translational Research And Early Development At Mercaptor

10/2/2017
Mercaptor Appoints Three New Members, Including Former NFL Linebacker, To Board Of Directors

8/9/2017